In this recording from the 2023 Transcatheter Heart Valves Greece conference, Dr. Stefan Anker, a cardiothoracic surgeon, professor, and researcher at Charite Medical School in Berlin, Germany, gave the meeting’s keynote lecture. He discussed an update in research for TEER for FMR in heart failure patients.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transcatheter
December 20, 2023
The incidence, predictors, and prognostic impact of rehospitalization following transcatheter aortic valve implantation (TAVI) has not been widely investigated and reported. This information is especially missing based on real-world practice data.
December 15, 2023
In this recording from the 2023 Transcatheter Heart Valves Greece conference, Dr. Christina Chrysohoou, a cardiothoracic surgeon at the University of Athens, discusses tailoring TEER to individual patients who are in heart failure.
December 14, 2023
Non-inferiority study designs are frequently used in randomized controlled trials (RCT) comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). However, the long-term outcomes of TAVR are unknown, and the concept of non-inferiority is challenging to define and assess.
December 7, 2023
Degenerative aortic valve stenosis is the most frequent valvular heart disease in western countries, and valve replacement is the gold standard for symptomatic severe cases.
November 15, 2023
A review of voluntary international multi-registry data on salvage of failed catheter insertion of stent grafts for aortic aneurysms
November 10, 2023
In this recording from the 2023 Transcatheter Heart Valves Greece conference, Dr. Michael J. Reardon, a cardiothoracic surgeon at Methodist DeBaket Heart and Vascular Center, discusses varying confidence in the shift in TAVI guidelines from operative risk to age.
November 9, 2023
In this meta‐analysis, the authors performed a pooled analysis of time‐to‐event data from Kaplan-Meier curves of randomized controlled trials (RCTs) and propensity‐score matched (PSM) studies comparing transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in low-risk patients.
November 1, 2023
The Society of Thoracic Surgeons (STS) and the European Association of Cardio-Thoracic Surgery (EACTS) published a joint press release regarding aortic valve replacement in low-risk patients.
October 26, 2023
The outcomes of the Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years (5y PARTNER 3 trial) were presented during the late-breaking clinical trial session of TCT 2023 and simultaneously published in the New England Journal of Medicine.